Fluidigm Announces Fourth Quarter and Full Year 2020 Financial Results
February 10, 2021 16:05 ET
|
Fluidigm Corporation
Fourth Quarter Total Revenue Increased 38 Percent to $44.6 million Fourth Quarter Product and Service Revenue Increased 26 Percent to $40.5 million Full Year Total Revenue Increased 18 Percent to...
Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 04, 2021 16:02 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Brain Scientific Unveils New Initiative to Develop Brain E-Tattoo Device for the Brain Diagnostics Market
January 21, 2021 08:30 ET
|
Brain Scientific Inc.
Powered by A.I., Brain E-Tattoo Technology is Expected to Provide Continuous Monitoring for Uninterrupted Data Collection in Patients with Epilepsy, Alzheimer’s, Stroke, and More. NEW YORK, Jan. 21,...
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Financial Results
January 07, 2021 16:02 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children
December 17, 2020 08:30 ET
|
Brain Scientific Inc.
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has announced its next generation...
Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
December 15, 2020 08:30 ET
|
Brain Scientific Inc.
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a...
HalioDx Partners with DASA, the Largest Diagnostics Provider in Latin America, to make Immunoscore® available in Brazil
December 10, 2020 07:45 ET
|
HalioDx
HalioDx Partners with DASA, the Largest Diagnostics Provider in Latin America, to make Immunoscore® available in Brazil Marseille, France, December 10, 2020 HalioDx SAS, the immuno-oncology...
New Study Demonstrates Clinical Utility of PrismRA® Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients
December 07, 2020 08:06 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announced findings from a clinical utility...
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 20, 2020 21:54 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
New Research Reveals Gazelle Diagnostic Device Outperformed Rapid Diagnostic Test for P. Vivax Malaria, Detected Challenging Types of Malaria, and Provided Affordable Sickle Cell Disease Detection
November 16, 2020 16:10 ET
|
Hemex Health
PORTLAND, Ore., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Hemex Health, an innovator in point-of-care diagnostic technologies, announced today that researchers will present five scientific posters at the...